Macacine alphaherpesvirus 1: Difference between revisions
From IDWiki
(→: added section) |
(→) |
||
| (9 intermediate revisions by the same user not shown) | |||
| Line 3: | Line 3: | ||
=== History === |
=== History === |
||
| + | * First described in 1933[[CiteRef::gay1933is]], named 'B' for the first patient's initial |
||
| − | * First diagnosed in a researcher in 1933 |
||
=== Microbiology === |
=== Microbiology === |
||
* Double-stranded DNA virus |
* Double-stranded DNA virus |
||
* Alphaherpesvirus, in the same family as [[HSV]] |
* Alphaherpesvirus, in the same family as [[HSV]] |
||
| + | |||
| + | === Epidemiology === |
||
| + | * 50 documented cases worldwide, in people who handle macaques or their lab samples |
||
=== Pathophysiology === |
=== Pathophysiology === |
||
* Virus replicates locally at the site of inoculation, then spreads from peripheral nerves to spinal cord to brainstem to brain |
* Virus replicates locally at the site of inoculation, then spreads from peripheral nerves to spinal cord to brainstem to brain |
||
| − | == Clinical |
+ | == Clinical Manifestations == |
* Typically via bite or scratch of macaque monkey |
* Typically via bite or scratch of macaque monkey |
||
** Asymptomatic or similar presentation to HSV in the monkey |
** Asymptomatic or similar presentation to HSV in the monkey |
||
** Seroprevalence reaches 100% in some populations of macaques |
** Seroprevalence reaches 100% in some populations of macaques |
||
| − | * Incubation period 5 to 21 days (range 2 days to 5 weeks) |
+ | * Incubation period [[Usual incubation period::5 to 21 days]] (range [[Incubation period range::2 days to 5 weeks]]) |
* Three clinical forms: |
* Three clinical forms: |
||
** Flu-like illness followed by CNS symptoms |
** Flu-like illness followed by CNS symptoms |
||
** Local symptoms (itching, tingling, numbness, or pain) at the inoculation site, with or without vesicular rash and regional lymphadenopathy |
** Local symptoms (itching, tingling, numbness, or pain) at the inoculation site, with or without vesicular rash and regional lymphadenopathy |
||
** Peripheral or central nervous system symptoms, with meningismus, vomiting, confusion, cranial nerve palsies |
** Peripheral or central nervous system symptoms, with meningismus, vomiting, confusion, cranial nerve palsies |
||
| + | ** There has been a single case of reactivation 10 years after last macaque exposure[[CiteRef::fierer1973he]] |
||
* Eventually progresses to global encephalitis, seizures, paralysis, and respiratory failure |
* Eventually progresses to global encephalitis, seizures, paralysis, and respiratory failure |
||
| − | * Mortality 70% if untreated |
+ | * Mortality 70-80% if untreated |
== Diagnosis == |
== Diagnosis == |
||
| Line 37: | Line 41: | ||
== Management == |
== Management == |
||
| − | + | === Initial management === |
|
| − | + | * Local wound irrigation, flushing for 15 minutes |
|
| − | + | * Assess risk: |
|
| − | + | ** Source of exposure: must be a [http://biotech.gsu.edu/virology/VirusInfo/macaque.html macaque], as there are no other known hosts. Captive macaques have up to 100% seropositivity, depending on age. |
|
| − | + | ** First aid: risk decreases with flushing for 15 minutes |
|
| − | + | ** Type of wound: risk is higher with deeper wounds (e.g. bites) and larger area, as well as with high-risk areas (head, neck, or torso) |
|
| − | + | * Consider sending wound swab and baseline serology |
|
| + | ** CDC recommends ''against'' routine swabbing |
||
| − | + | ** Contact the lab, especially if you will be sending PCR |
|
| ⚫ | |||
| + | |||
| + | === Treatment of diagnosed infection === |
||
| + | * [[Is treated by::Acyclovir]] 12.5 to 15 mg/kg IV q8h |
||
| + | * Alternative: [[Is treated by::ganciclovir]] 5 mg/kg IV q12h |
||
| + | * Duration at least 2 weeks and until resolution of symptoms and 2 negative cultures |
||
| + | |||
| + | === Postexposure prophylaxis === |
||
| ⚫ | |||
** Should be started within hours |
** Should be started within hours |
||
| − | ** First-line treatment: [[Is treated by:valacyclovir]] 1 g po tid |
+ | ** First-line treatment: [[Is treated by::valacyclovir]] 1 g po tid |
** Alternatives: [[Is treated by::acyclovir]] 800 mg po 5 times daily, or [[Is treated by::famciclovir]] 500 mg po 5 times daily |
** Alternatives: [[Is treated by::acyclovir]] 800 mg po 5 times daily, or [[Is treated by::famciclovir]] 500 mg po 5 times daily |
||
** Continue for 2 weeks (some recommend up to 5 weeks, the longest known incubation period) |
** Continue for 2 weeks (some recommend up to 5 weeks, the longest known incubation period) |
||
Latest revision as of 09:46, 5 August 2020
Background
- Also known as macacine herpesvirus 1, macacine alphaherpesvirus 1, cercopithecine herpesvirus 1, CHV-1), herpes B virus, monkey B virus, herpesvirus simiae and herpesvirus B
History
- First described in 19331, named 'B' for the first patient's initial
Microbiology
- Double-stranded DNA virus
- Alphaherpesvirus, in the same family as HSV
Epidemiology
- 50 documented cases worldwide, in people who handle macaques or their lab samples
Pathophysiology
- Virus replicates locally at the site of inoculation, then spreads from peripheral nerves to spinal cord to brainstem to brain
Clinical Manifestations
- Typically via bite or scratch of macaque monkey
- Asymptomatic or similar presentation to HSV in the monkey
- Seroprevalence reaches 100% in some populations of macaques
- Incubation period 5 to 21 days (range 2 days to 5 weeks)
- Three clinical forms:
- Flu-like illness followed by CNS symptoms
- Local symptoms (itching, tingling, numbness, or pain) at the inoculation site, with or without vesicular rash and regional lymphadenopathy
- Peripheral or central nervous system symptoms, with meningismus, vomiting, confusion, cranial nerve palsies
- There has been a single case of reactivation 10 years after last macaque exposure2
- Eventually progresses to global encephalitis, seizures, paralysis, and respiratory failure
- Mortality 70-80% if untreated
Diagnosis
- Serology, with acute and convalescent (3 to 6 weeks) titres, looking for a 4-fold rise
- Seroconversion may be delayed if on acyclovir, so should be repeated at 12 weeks
- Done at NML or sent out to Georgia State University
- Viral culture is possible but not done routinely
- PCR is available for swab, tissue, blood, and CSF
- Sent out to Georgia State University
- In autopsy, send right and left trigeminal ganglia or the sacral dorsal root ganglia
Management
Initial management
- Local wound irrigation, flushing for 15 minutes
- Assess risk:
- Source of exposure: must be a macaque, as there are no other known hosts. Captive macaques have up to 100% seropositivity, depending on age.
- First aid: risk decreases with flushing for 15 minutes
- Type of wound: risk is higher with deeper wounds (e.g. bites) and larger area, as well as with high-risk areas (head, neck, or torso)
- Consider sending wound swab and baseline serology
- CDC recommends against routine swabbing
- Contact the lab, especially if you will be sending PCR
Treatment of diagnosed infection
- Acyclovir 12.5 to 15 mg/kg IV q8h
- Alternative: ganciclovir 5 mg/kg IV q12h
- Duration at least 2 weeks and until resolution of symptoms and 2 negative cultures
Postexposure prophylaxis
- Recommended for everyone with skin or mucosal exposure to a captive macaque, and there was inadequate cleaning (deep puncture bites are assumed to not be adequately cleaned)
- Should be started within hours
- First-line treatment: valacyclovir 1 g po tid
- Alternatives: acyclovir 800 mg po 5 times daily, or famciclovir 500 mg po 5 times daily
- Continue for 2 weeks (some recommend up to 5 weeks, the longest known incubation period)
References
- ^ F. P. Gay, M. Holden. Isolation of a Herpes Virus from Several Cases of Epidemic Encephalitis.. Experimental Biology and Medicine. 1933;30(8):1051-1053. doi:10.3181/00379727-30-6788.
- ^ Joshua Fierer. Herpes B Virus Encephalomyelitis Presenting as Ophthalmic Zoster. Annals of Internal Medicine. 1973;79(2):225. doi:10.7326/0003-4819-79-2-225.
